Sansan Chen

487 total citations
25 papers, 369 citations indexed

About

Sansan Chen is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Sansan Chen has authored 25 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Sansan Chen's work include Acupuncture Treatment Research Studies (4 papers), Beetle Biology and Toxicology Studies (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Sansan Chen is often cited by papers focused on Acupuncture Treatment Research Studies (4 papers), Beetle Biology and Toxicology Studies (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Sansan Chen collaborates with scholars based in China, United States and Hong Kong. Sansan Chen's co-authors include Wanlong Tan, Sen Wang, You Luo, Wanlong Tan, Zhiming Hu, Shiyu Pang, Li Luo, Chengyong Lei, Xinglu Chen and Pei Wan and has published in prestigious journals such as Medicine, Oncotarget and Journal of Proteomics.

In The Last Decade

Sansan Chen

25 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sansan Chen China 13 190 136 99 68 54 25 369
Songfeng Wei China 10 157 0.8× 75 0.6× 84 0.8× 52 0.8× 208 3.9× 23 360
Haojun Yang China 13 199 1.0× 92 0.7× 57 0.6× 73 1.1× 10 0.2× 38 380
Jianxu Chen China 11 178 0.9× 158 1.2× 55 0.6× 89 1.3× 23 0.4× 15 384
Mosin Saleem Khan India 13 205 1.1× 55 0.4× 32 0.3× 92 1.4× 103 1.9× 39 417
Mitchell I. Parker United States 10 145 0.8× 55 0.4× 31 0.3× 61 0.9× 60 1.1× 15 294
Hong Ji China 13 253 1.3× 179 1.3× 27 0.3× 94 1.4× 20 0.4× 31 441
Weihao Chen China 9 146 0.8× 66 0.5× 43 0.4× 62 0.9× 9 0.2× 25 317
Lorena Blanco Spain 13 162 0.9× 95 0.7× 84 0.8× 271 4.0× 85 1.6× 23 450
Yanna Ba China 9 166 0.9× 163 1.2× 45 0.5× 151 2.2× 16 0.3× 16 346
Raksha R. Bhat United States 11 125 0.7× 42 0.3× 23 0.2× 77 1.1× 22 0.4× 19 296

Countries citing papers authored by Sansan Chen

Since Specialization
Citations

This map shows the geographic impact of Sansan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sansan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sansan Chen more than expected).

Fields of papers citing papers by Sansan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sansan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sansan Chen. The network helps show where Sansan Chen may publish in the future.

Co-authorship network of co-authors of Sansan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Sansan Chen. A scholar is included among the top collaborators of Sansan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sansan Chen. Sansan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jia, Min, Xiuyun Wang, Yongjun Zhang, et al.. (2020). Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity. International Journal of Medical Sciences. 17(11). 1652–1664. 7 indexed citations
3.
Chen, Sansan, Jianbin Zhu, Jingjing Li, et al.. (2019). Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on erectile dysfunction in diabetic rats. International Journal of Molecular Medicine. 44(3). 1006–1014. 25 indexed citations
4.
Chen, Sansan, Yongjun Zhang, Weiwei Xie, et al.. (2019). <p>Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation</p>. OncoTargets and Therapy. Volume 12. 4403–4413. 13 indexed citations
5.
Chen, Sansan, et al.. (2018). Acupuncture on back-shu points of five zang for chronic fatigue syndrome: A randomized control trial. World Journal of Acupuncture - Moxibustion. 28(4). 237–241. 6 indexed citations
6.
Luo, You, et al.. (2017). The efficacy of radiation therapy in adrenocortical carcinoma. Medicine. 96(17). e6741–e6741. 13 indexed citations
7.
Qi, Honggang, Yeping Li, Sansan Chen, et al.. (2017). SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer. Oncology Letters. 13(4). 2577–2582. 21 indexed citations
8.
Tan, Wanlong, Yeping Li, Bing Cai, et al.. (2017). Overexpression of Tat-interacting protein 30 inhibits the proliferation, migration, invasion and promotes apoptosis in bladder cancer cells. Journal of Cancer Research and Therapeutics. 14(10). 713–713. 3 indexed citations
9.
Wang, Sen, et al.. (2017). Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database. OncoTargets and Therapy. Volume 10. 5311–5315. 19 indexed citations
10.
11.
Yang, Jing‐Wen, Liwen Zhang, Guang‐Xia Shi, et al.. (2017). Acupuncture for postprandial distress syndrome (APDS): study protocol for a randomized controlled trial. Trials. 18(1). 537–537. 5 indexed citations
12.
Tao, Sha, Xinji Zhang, Sansan Chen, et al.. (2016). Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis. International Journal of Surgery. 27. 39–45. 4 indexed citations
13.
Chen, Xinglu, Sansan Chen, Yingying Mao, et al.. (2016). AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo. Oncotarget. 8(1). 354–363. 18 indexed citations
14.
Chen, Sansan, Xinglu Chen, Guie Xie, et al.. (2016). Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells. Oncotarget. 7(26). 40362–40376. 42 indexed citations
15.
Li, Shi, Zhe Yu, Sansan Chen, et al.. (2015). The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA. Urologic Oncology Seminars and Original Investigations. 33(10). 427.e1–427.e10. 51 indexed citations
16.
Zhu, Yongtong, Zhen Zhao, Yang Luo, et al.. (2014). The granulocyte macrophage–colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer. Stem Cell Research. 13(1). 111–122. 26 indexed citations
17.
Chen, Sansan, Pei Wan, Wenqi Ding, et al.. (2013). Norcantharidin inhibits DNA replication and induces mitotic catastrophe by degrading initiation protein Cdc6. International Journal of Molecular Medicine. 32(1). 43–50. 14 indexed citations
18.
Li, Fei, You Zhou, Vesa M. Olkkonen, et al.. (2012). Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). Journal of Proteomics. 77. 225–236. 33 indexed citations
19.
Jing, Yuming, Jie Luo, Yanling Zhang, et al.. (2012). [Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].. PubMed. 32(3). 317–21. 1 indexed citations
20.
Shi, Xiaojun, Xinji Zhang, Jin‐Long Li, et al.. (2011). Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer. Urologic Oncology Seminars and Original Investigations. 31(6). 883–893. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026